Beaumont Financial Partners, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Beaumont Financial Partners, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2022$8,221,000
-23.9%
127,989
-8.1%
0.74%
-10.2%
Q1 2022$10,803,000
-3.8%
139,318
+6.5%
0.82%
+0.9%
Q4 2021$11,233,000
+23.2%
130,858
+15.4%
0.82%
+15.9%
Q3 2021$9,118,000
+16.8%
113,366
-0.5%
0.70%
-44.6%
Q1 2016$7,807,000
+451.0%
113,974
+462.4%
1.27%
+519.0%
Q3 2015$1,417,0000.0%20,2660.0%0.20%0.0%
Q2 2015$1,417,000
-82.9%
20,266
-83.3%
0.20%
-29.1%
Q1 2015$8,305,000
-5.0%
121,248
+1.7%
0.29%
-31.4%
Q4 2014$8,739,000
+11.9%
119,238
+9.6%
0.42%
-17.5%
Q3 2014$7,808,000
+19.9%
108,786
+20.7%
0.51%
+10.4%
Q2 2014$6,514,000
+60.4%
90,092
+63.3%
0.46%
+38.7%
Q1 2014$4,060,00055,1750.33%
Other shareholders
BAXTER INTL INC shareholders Q3 2014
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders